UK Pharma Exports To Fall 22% In No-Deal Brexit

Third Countries Would Benefit From Europe’s Loss

 
• By Ian Schofield
  
Decreasing_Graph
A no-deal Brexit would see a decline in UK and EU pharma competitiveness • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance